Glioblastoma is an aggressive brain cancer that has no cure. A recent chart study of patients with glioblastoma found that taking chemotherapy in the morning was associated with a three- to six-month increase in median survival. Now a study from Washington University in St. Louis reports that glioblastoma cells have built-in circadian rhythms that create better […]
Tag: Joshua Rubin
NIH funds study of ultrasound with genetics to treat brain disorders
Researchers have developed methods to study and manipulate areas of the brain, though many of those methods are restricted by the limited depth that light can reach within the brain. A multidisciplinary team at Washington University in St. Louis plans to overcome that limitation by integrating ultrasound with genetics to precisely modify neurons in the […]
Chemo for glioblastoma may work better in morning than evening
An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years. While researchers are investigating potential new therapies via ongoing clinical trials, a new study from Washington University in St. Louis suggests that a minor adjustment […]
Brain Tumor Center established at Siteman Cancer Center
Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital have established the Brain Tumor Center, a multidisciplinary practice of physicians and scientists whose mission is to provide leading-edge, patient-centric care for brain tumor patients while also developing transformative basic, translational and clinical research to develop new therapies and improve patient outcomes. Neurosurgeon and scientist Albert H. Kim, […]
Basis of developmental disabilities focus of $11.3 million in grants
Researchers at Washington University School of Medicine in St. Louis have received a pair of grants totaling $11.3 million to study genetic and environmental factors that contribute to developmental disabilities and to find new ways to improve the lives of children and adults affected by such disabilities. The grants — a five-year award from the […]
When it comes to brain tumors, a patient’s sex matters
From The Conversation… Have you ever wondered why, in most species, males are larger and more ornamented than females? It’s an evolutionarily determined aspect of biology, but what does it mean for human health and disease? What are the implications of needing one chart to describe normal growth in boys, and another to describe normal growth […]
Sex differences identified in deadly brain tumors
Tailoring treatment to men, women may improve survival From the WashU School of Medicine News… For decades, scientists have recognized that more males get cancer and die of the disease than females. This is true for many types of cancer, including the deadly brain tumor glioblastoma. Now, a team of researchers led by Washington University […]
Focused delivery for brain cancers
Interdisciplinary research brings together imaging, aerosols and pediatric neuro oncology to fight tumors From the WashU Newsroom… A person’s brainstem controls some of the body’s most important functions, including heart beat, respiration, blood pressure and swallowing. Tumor growth in this part of the brain is therefore twice as devastating. Not only can such a growth […]
Rubin recognized by Children’s Brain Tumor Foundation
Honored for research, patient care From the WashU School of Medicine News… Joshua B. Rubin, MD, PhD, a professor of pediatrics and of neuroscience at Washington University School of Medicine in St. Louis, has received the Pioneer Award for Pediatric Neuro-Oncology from the Children’s Brain Tumor Foundation. The charitable organization honored Rubin on June 6 […]